Learning and research

User account menu

Join
Log in

Main navigation

Upcoming events
Learning and research
IDDI Workstreams & Task Forces
Membership
Pulmonary hypertension
Support us
About us

User account menu

Join
Log in

Breadcrumb

Home
Learning and Research

Pagination

Previous page
Page 46

Related content

GoDeep Global PH Registry
PVRI Digital Webinar Series
Pulmonary Circulation
Pulmonary Hypertension Global Patient Survey (PH GPS)
Latest news

Fulltext search

Reset filters

Fulltext search

Publication Types

Pulmonary Circulation
IDDI Workstream or Task Force Learning
PVRI Digital Webinar Series
PVRI Community Calls
PVRI 2025 DDDS
PVRI 2025 Rio
PVRI 2024 London
PVRI 2023 DDDS
PVRI 2022 Athens

Subjects

Basic research and pathophysiology
- Cellular and molecular biology
- Genetics/genomics and other Omics
- Immunology and inflammation
- Infections and PVD
- Right ventricle
Diagnostic and assessment methods
- 1MWT, 6MWT, Incremental shuttle walk test
- Biomarkers
- Cardiopulmonary exercise test
- Genetic markers
- Hemodynamic assessments
- Imaging techniques
- Pulmonary function test
Diseases and clinical manifestations
- Group 1: Pulmonary Arterial Hypertension (PAH)
- Group 2: PH associated with left heart disease
- Group 3: PH associated with lung disease and/or hypoxia
- Group 4: PH associated with pulmonary artery obstruction / CTEPH
- Group 5: PH with unclear and/or multifactorial mechanisms
- Paediatric PH
- Exercise-induced PH
- Other lung disorders relevant to PH
- Related cardiovascular conditions
Emerging trends and future research
- Emerging therapies
- Novel clinical trial designs in PH
- Policy and guidelines
- Technological advances
Epidemiology and public health
- Global health and PH
- Incidence, prevalence, and risk factors
- Population studies and public health initiatives
Patient care and advocacy
- Advocacy and quality of life improvement
- Palliative care in PH
- Psychosocial aspects and patient education
- Special circumstances
- Symptom management
Treatment
- Perioperative care
- PH-specific therapies
- Special populations
- Supportive therapy
- Surgical and interventional procedures

28 February 2023

February 2023 PVRI Community Call with Jason Zelt

In this Community Call, we discussed:

G9a/GLP Targeting Ameliorates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
Right Ventricular Maladaptation to Pressure Overload in Fischer Rats is Associated with Profound Deficiency in Adenylate Kinase 1 and Impaired Ventricular Energetics
Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression

PVRI Community Calls

26 January 2023

January 2023 PVRI Community Call with Daphne Moutsoglou

In this Community Call, we discussed:

Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension
Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites

PVRI Community Calls

17 August 2022

The immune landscape of HIV and schistosomiasis co-infection

An oral presentation delivered at PVRI 2022 Congress (iPVD symposium) by Sandra Garcia, Universidad Complutense de Madrid

Members Only

Member content

17 August 2022

Scars that never felt a wound: Post COVID-19 Pulmonary fibrosis and PVD

An oral presentation delivered at PVRI 2022 Congress (iPVD symposium) by Andrew J Bryant, University of Florida

Members Only

Member content

17 August 2022

The role of COVID-19 in the right ventricular function and exercise tolerance

An oral presentation delivered at PVRI 2022 Congress (iPVD symposium) by Rudolf Oliveira, Federal University of São Paulo

Members Only

Member content

17 August 2022

Effect of HIV on PAH role of HIV-Nef and EMAP II

An oral presentation delivered at PVRI 2022 Congress (iPVD symposium) by Matthias Clauss, Indiana University School of Medicine

Members Only

Member content

17 August 2022

The clinical management of PH patients during the COVID-19 Pandemic

An oral presentation delivered at PVRI 2022 Congress (iPVD symposium) by Luke Howard, Imperial College London

Members Only

Member content

17 August 2022

High altitude and COVID-19: potential effects on pulmonary circulation

An oral presentation delivered at PVRI 2022 Congress (iPVD symposium) by Djuro Kosanovic, Sechenov First Moscow State Medical University

Members Only

Member content

17 August 2022

Regulation of lysosomal activity reprograms lung endothelial sterol metabolism to control SARS-CoV2 entry and COVID-19

An oral presentation delivered at PVRI 2022 Congress (iPVD symposium) by Stephen Chan, University of Pittsburgh

Members Only

Member content

17 August 2022

COVID-19 and PVD: Lessons learned from HIV associated pulmonary disease

An oral presentation delivered at PVRI 2022 Congress (iPVD symposium) by Navneet Dhillon, Kansas University Medical Center

Members Only

Member content

Pagination

First page First

Previous page Previous

…

Page 46

Current page 47

Page 48

Page 49

…

Next page Next

Last page Last

Footer Menu

GET LEARNING
- Attend an event
- Keep up with PVD developments
GET CONNECTED
GET INVOLVED

Footer menu - pages

Accessibility
Code of Conduct
Complaints
Privacy Policy
Cookies Policy
Social Media Policy
Terms & Conditions

The Pulmonary Vascular Research Institute (PVRI) is a charity registered in England & Wales no. 1127115 and a Company Limited by Guarantee no. 05780068. VAT registration no. 488 0247 66. Registered office: 5 Tanner Street, London SE1 3LE. Phone number: + 44 (0) 7934 126930.

Translate this page